nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—SLC22A1—prostate cancer	0.495	1	CbGaD
Vecuronium—SLC22A1—Estradiol—prostate cancer	0.0664	0.195	CbGbCtD
Vecuronium—ABCB1—Estramustine—prostate cancer	0.055	0.161	CbGbCtD
Vecuronium—ABCB1—Cabazitaxel—prostate cancer	0.0362	0.106	CbGbCtD
Vecuronium—ABCB1—Estrone—prostate cancer	0.0354	0.104	CbGbCtD
Vecuronium—ABCB1—Ethinyl Estradiol—prostate cancer	0.0316	0.0925	CbGbCtD
Vecuronium—ABCB1—Conjugated Estrogens—prostate cancer	0.0232	0.0679	CbGbCtD
Vecuronium—ABCB1—Mitoxantrone—prostate cancer	0.0211	0.0617	CbGbCtD
Vecuronium—ABCB1—Estradiol—prostate cancer	0.0203	0.0596	CbGbCtD
Vecuronium—ABCB1—Prednisone—prostate cancer	0.0175	0.0513	CbGbCtD
Vecuronium—ABCB1—Etoposide—prostate cancer	0.0133	0.0389	CbGbCtD
Vecuronium—ABCB1—Docetaxel—prostate cancer	0.0122	0.0356	CbGbCtD
Vecuronium—ABCB1—Doxorubicin—prostate cancer	0.00906	0.0266	CbGbCtD
Vecuronium—Rocuronium—SLC22A1—prostate cancer	0.00165	0.512	CrCbGaD
Vecuronium—Pancuronium—SLC22A1—prostate cancer	0.00157	0.488	CrCbGaD
Vecuronium—Rash erythematous—Docetaxel—prostate cancer	0.000676	0.00533	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Degarelix—prostate cancer	0.000667	0.00526	CcSEcCtD
Vecuronium—Angiopathy—Bicalutamide—prostate cancer	0.000664	0.00524	CcSEcCtD
Vecuronium—Nervous system disorder—Estradiol valerate/Dienogest—prostate cancer	0.000664	0.00524	CcSEcCtD
Vecuronium—Immune system disorder—Bicalutamide—prostate cancer	0.000661	0.00522	CcSEcCtD
Vecuronium—CHRNA1—prostate gland—prostate cancer	0.000661	0.231	CbGeAlD
Vecuronium—Mediastinal disorder—Bicalutamide—prostate cancer	0.00066	0.00521	CcSEcCtD
Vecuronium—Rash erythematous—Capecitabine—prostate cancer	0.000655	0.00516	CcSEcCtD
Vecuronium—Anaphylactic shock—Degarelix—prostate cancer	0.000644	0.00508	CcSEcCtD
Vecuronium—Myopathy—Prednisone—prostate cancer	0.000637	0.00502	CcSEcCtD
Vecuronium—Nervous system disorder—Degarelix—prostate cancer	0.000631	0.00498	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Cabazitaxel—prostate cancer	0.000628	0.00496	CcSEcCtD
Vecuronium—Skin disorder—Degarelix—prostate cancer	0.000625	0.00493	CcSEcCtD
Vecuronium—Bronchospasm—Conjugated Estrogens—prostate cancer	0.00062	0.00489	CcSEcCtD
Vecuronium—Urticaria—Estrone—prostate cancer	0.000616	0.00486	CcSEcCtD
Vecuronium—Injection site pain—Capecitabine—prostate cancer	0.000614	0.00484	CcSEcCtD
Vecuronium—Connective tissue disorder—Ethinyl Estradiol—prostate cancer	0.000608	0.0048	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Estradiol—prostate cancer	0.000603	0.00476	CcSEcCtD
Vecuronium—Hypotension—Degarelix—prostate cancer	0.000602	0.00474	CcSEcCtD
Vecuronium—Nervous system disorder—Cabazitaxel—prostate cancer	0.000595	0.00469	CcSEcCtD
Vecuronium—Tachycardia—Cabazitaxel—prostate cancer	0.000592	0.00467	CcSEcCtD
Vecuronium—Skin disorder—Cabazitaxel—prostate cancer	0.000589	0.00465	CcSEcCtD
Vecuronium—Angioedema—Bicalutamide—prostate cancer	0.000582	0.00459	CcSEcCtD
Vecuronium—Hypotension—Cabazitaxel—prostate cancer	0.000567	0.00447	CcSEcCtD
Vecuronium—Face oedema—Estradiol—prostate cancer	0.000564	0.00444	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Mitoxantrone—prostate cancer	0.000562	0.00443	CcSEcCtD
Vecuronium—Angiopathy—Ethinyl Estradiol—prostate cancer	0.000562	0.00443	CcSEcCtD
Vecuronium—Immune system disorder—Ethinyl Estradiol—prostate cancer	0.000559	0.00441	CcSEcCtD
Vecuronium—CHRNA2—prostate gland—prostate cancer	0.000548	0.191	CbGeAlD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Bicalutamide—prostate cancer	0.000539	0.00425	CcSEcCtD
Vecuronium—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.000538	0.00424	CcSEcCtD
Vecuronium—Respiratory failure—Docetaxel—prostate cancer	0.000527	0.00416	CcSEcCtD
Vecuronium—Redness—Epirubicin—prostate cancer	0.000518	0.00408	CcSEcCtD
Vecuronium—Injection site reaction—Docetaxel—prostate cancer	0.000515	0.00406	CcSEcCtD
Vecuronium—Rash—Estramustine—prostate cancer	0.000512	0.00404	CcSEcCtD
Vecuronium—Shock—Bicalutamide—prostate cancer	0.000512	0.00404	CcSEcCtD
Vecuronium—Dermatitis—Estramustine—prostate cancer	0.000512	0.00404	CcSEcCtD
Vecuronium—Urticaria—Degarelix—prostate cancer	0.000511	0.00403	CcSEcCtD
Vecuronium—Nervous system disorder—Bicalutamide—prostate cancer	0.00051	0.00402	CcSEcCtD
Vecuronium—CHRNB1—prostate gland—prostate cancer	0.00051	0.178	CbGeAlD
Vecuronium—Skin disorder—Bicalutamide—prostate cancer	0.000505	0.00399	CcSEcCtD
Vecuronium—Paralysis—Epirubicin—prostate cancer	0.000503	0.00397	CcSEcCtD
Vecuronium—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000499	0.00393	CcSEcCtD
Vecuronium—Injection site reaction—Capecitabine—prostate cancer	0.000499	0.00393	CcSEcCtD
Vecuronium—Rash—Abiraterone—prostate cancer	0.000497	0.00392	CcSEcCtD
Vecuronium—Dermatitis—Abiraterone—prostate cancer	0.000497	0.00392	CcSEcCtD
Vecuronium—Bronchospasm—Estradiol—prostate cancer	0.000496	0.00391	CcSEcCtD
Vecuronium—Angioedema—Ethinyl Estradiol—prostate cancer	0.000492	0.00388	CcSEcCtD
Vecuronium—Rash—Estrone—prostate cancer	0.000489	0.00386	CcSEcCtD
Vecuronium—Dermatitis—Estrone—prostate cancer	0.000489	0.00385	CcSEcCtD
Vecuronium—Redness—Doxorubicin—prostate cancer	0.000479	0.00378	CcSEcCtD
Vecuronium—Hypersensitivity—Degarelix—prostate cancer	0.000474	0.00374	CcSEcCtD
Vecuronium—Cardiac disorder—Goserelin—prostate cancer	0.000473	0.00373	CcSEcCtD
Vecuronium—Cardiac disorder—Conjugated Estrogens—prostate cancer	0.000468	0.00369	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Etoposide—prostate cancer	0.000467	0.00369	CcSEcCtD
Vecuronium—Paralysis—Doxorubicin—prostate cancer	0.000465	0.00367	CcSEcCtD
Vecuronium—Angiopathy—Goserelin—prostate cancer	0.000462	0.00365	CcSEcCtD
Vecuronium—Immune system disorder—Goserelin—prostate cancer	0.00046	0.00363	CcSEcCtD
Vecuronium—Angiopathy—Conjugated Estrogens—prostate cancer	0.000458	0.00361	CcSEcCtD
Vecuronium—Rash erythematous—Epirubicin—prostate cancer	0.000456	0.0036	CcSEcCtD
Vecuronium—Immune system disorder—Conjugated Estrogens—prostate cancer	0.000456	0.00359	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—prostate cancer	0.000456	0.00359	CcSEcCtD
Vecuronium—Mediastinal disorder—Conjugated Estrogens—prostate cancer	0.000455	0.00359	CcSEcCtD
Vecuronium—Rash—Nilutamide—prostate cancer	0.000454	0.00358	CcSEcCtD
Vecuronium—Dermatitis—Nilutamide—prostate cancer	0.000454	0.00358	CcSEcCtD
Vecuronium—Rash—Flutamide—prostate cancer	0.000452	0.00357	CcSEcCtD
Vecuronium—Dermatitis—Flutamide—prostate cancer	0.000452	0.00356	CcSEcCtD
Vecuronium—Hypersensitivity—Cabazitaxel—prostate cancer	0.000447	0.00352	CcSEcCtD
Vecuronium—Erythema—Goserelin—prostate cancer	0.000443	0.0035	CcSEcCtD
Vecuronium—Erythema—Conjugated Estrogens—prostate cancer	0.000439	0.00346	CcSEcCtD
Vecuronium—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000431	0.0034	CcSEcCtD
Vecuronium—Injection site pain—Epirubicin—prostate cancer	0.000428	0.00337	CcSEcCtD
Vecuronium—Skin disorder—Ethinyl Estradiol—prostate cancer	0.000427	0.00337	CcSEcCtD
Vecuronium—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000427	0.00337	CcSEcCtD
Vecuronium—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000427	0.00336	CcSEcCtD
Vecuronium—Rash erythematous—Doxorubicin—prostate cancer	0.000422	0.00333	CcSEcCtD
Vecuronium—Urticaria—Bicalutamide—prostate cancer	0.000413	0.00326	CcSEcCtD
Vecuronium—Rash—Degarelix—prostate cancer	0.000406	0.0032	CcSEcCtD
Vecuronium—Dermatitis—Degarelix—prostate cancer	0.000406	0.0032	CcSEcCtD
Vecuronium—Angioedema—Conjugated Estrogens—prostate cancer	0.000401	0.00317	CcSEcCtD
Vecuronium—Connective tissue disorder—Estradiol—prostate cancer	0.000397	0.00313	CcSEcCtD
Vecuronium—Injection site pain—Doxorubicin—prostate cancer	0.000396	0.00312	CcSEcCtD
Vecuronium—Bronchospasm—Etoposide—prostate cancer	0.000385	0.00303	CcSEcCtD
Vecuronium—Hypersensitivity—Bicalutamide—prostate cancer	0.000383	0.00302	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.000375	0.00296	CcSEcCtD
Vecuronium—Cardiac disorder—Estradiol—prostate cancer	0.000375	0.00296	CcSEcCtD
Vecuronium—Flushing—Estradiol—prostate cancer	0.000375	0.00296	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.000371	0.00293	CcSEcCtD
Vecuronium—Angiopathy—Estradiol—prostate cancer	0.000366	0.00289	CcSEcCtD
Vecuronium—Immune system disorder—Estradiol—prostate cancer	0.000365	0.00288	CcSEcCtD
Vecuronium—Mediastinal disorder—Estradiol—prostate cancer	0.000364	0.00287	CcSEcCtD
Vecuronium—Anaphylactic shock—Goserelin—prostate cancer	0.000362	0.00285	CcSEcCtD
Vecuronium—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.000358	0.00283	CcSEcCtD
Vecuronium—Shock—Goserelin—prostate cancer	0.000356	0.00281	CcSEcCtD
Vecuronium—Nervous system disorder—Goserelin—prostate cancer	0.000355	0.0028	CcSEcCtD
Vecuronium—Tachycardia—Goserelin—prostate cancer	0.000353	0.00279	CcSEcCtD
Vecuronium—Shock—Conjugated Estrogens—prostate cancer	0.000353	0.00278	CcSEcCtD
Vecuronium—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000352	0.00277	CcSEcCtD
Vecuronium—Erythema—Estradiol—prostate cancer	0.000352	0.00277	CcSEcCtD
Vecuronium—Skin disorder—Goserelin—prostate cancer	0.000352	0.00277	CcSEcCtD
Vecuronium—Face oedema—Capecitabine—prostate cancer	0.000351	0.00277	CcSEcCtD
Vecuronium—Tachycardia—Conjugated Estrogens—prostate cancer	0.00035	0.00276	CcSEcCtD
Vecuronium—Urticaria—Ethinyl Estradiol—prostate cancer	0.000349	0.00276	CcSEcCtD
Vecuronium—Skin disorder—Conjugated Estrogens—prostate cancer	0.000348	0.00275	CcSEcCtD
Vecuronium—Injection site reaction—Epirubicin—prostate cancer	0.000347	0.00274	CcSEcCtD
Vecuronium—Hypotension—Goserelin—prostate cancer	0.000338	0.00267	CcSEcCtD
Vecuronium—Hypotension—Conjugated Estrogens—prostate cancer	0.000335	0.00264	CcSEcCtD
Vecuronium—Rash—Bicalutamide—prostate cancer	0.000328	0.00259	CcSEcCtD
Vecuronium—Dermatitis—Bicalutamide—prostate cancer	0.000328	0.00258	CcSEcCtD
Vecuronium—Erythema—Mitoxantrone—prostate cancer	0.000328	0.00258	CcSEcCtD
Vecuronium—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000324	0.00256	CcSEcCtD
Vecuronium—Injection site reaction—Doxorubicin—prostate cancer	0.000321	0.00253	CcSEcCtD
Vecuronium—Angioedema—Estradiol—prostate cancer	0.000321	0.00253	CcSEcCtD
Vecuronium—Muscular weakness—Capecitabine—prostate cancer	0.000321	0.00253	CcSEcCtD
Vecuronium—Bronchospasm—Docetaxel—prostate cancer	0.00032	0.00252	CcSEcCtD
Vecuronium—Face oedema—Prednisone—prostate cancer	0.000313	0.00247	CcSEcCtD
Vecuronium—Bronchospasm—Capecitabine—prostate cancer	0.000309	0.00244	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000297	0.00234	CcSEcCtD
Vecuronium—Cardiac disorder—Etoposide—prostate cancer	0.00029	0.00229	CcSEcCtD
Vecuronium—Flushing—Etoposide—prostate cancer	0.00029	0.00229	CcSEcCtD
Vecuronium—Urticaria—Goserelin—prostate cancer	0.000287	0.00227	CcSEcCtD
Vecuronium—Anaphylactic shock—Estradiol—prostate cancer	0.000287	0.00226	CcSEcCtD
Vecuronium—Muscular weakness—Prednisone—prostate cancer	0.000286	0.00226	CcSEcCtD
Vecuronium—Urticaria—Conjugated Estrogens—prostate cancer	0.000285	0.00225	CcSEcCtD
Vecuronium—Angiopathy—Etoposide—prostate cancer	0.000284	0.00224	CcSEcCtD
Vecuronium—Immune system disorder—Etoposide—prostate cancer	0.000283	0.00223	CcSEcCtD
Vecuronium—Shock—Estradiol—prostate cancer	0.000282	0.00223	CcSEcCtD
Vecuronium—Mediastinal disorder—Etoposide—prostate cancer	0.000282	0.00222	CcSEcCtD
Vecuronium—Nervous system disorder—Estradiol—prostate cancer	0.000281	0.00222	CcSEcCtD
Vecuronium—Tachycardia—Estradiol—prostate cancer	0.00028	0.00221	CcSEcCtD
Vecuronium—Skin disorder—Estradiol—prostate cancer	0.000279	0.0022	CcSEcCtD
Vecuronium—Rash—Ethinyl Estradiol—prostate cancer	0.000277	0.00219	CcSEcCtD
Vecuronium—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000277	0.00218	CcSEcCtD
Vecuronium—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000267	0.00211	CcSEcCtD
Vecuronium—Hypersensitivity—Goserelin—prostate cancer	0.000267	0.0021	CcSEcCtD
Vecuronium—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000264	0.00208	CcSEcCtD
Vecuronium—Shock—Mitoxantrone—prostate cancer	0.000263	0.00207	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000262	0.00207	CcSEcCtD
Vecuronium—Tachycardia—Mitoxantrone—prostate cancer	0.000261	0.00206	CcSEcCtD
Vecuronium—Skin disorder—Mitoxantrone—prostate cancer	0.00026	0.00205	CcSEcCtD
Vecuronium—Connective tissue disorder—Docetaxel—prostate cancer	0.000256	0.00202	CcSEcCtD
Vecuronium—Hypotension—Mitoxantrone—prostate cancer	0.00025	0.00197	CcSEcCtD
Vecuronium—Connective tissue disorder—Capecitabine—prostate cancer	0.000247	0.00195	CcSEcCtD
Vecuronium—Face oedema—Epirubicin—prostate cancer	0.000245	0.00193	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000242	0.00191	CcSEcCtD
Vecuronium—Flushing—Docetaxel—prostate cancer	0.000241	0.0019	CcSEcCtD
Vecuronium—Cardiac disorder—Docetaxel—prostate cancer	0.000241	0.0019	CcSEcCtD
Vecuronium—Angiopathy—Docetaxel—prostate cancer	0.000236	0.00186	CcSEcCtD
Vecuronium—Immune system disorder—Docetaxel—prostate cancer	0.000235	0.00185	CcSEcCtD
Vecuronium—Mediastinal disorder—Docetaxel—prostate cancer	0.000234	0.00185	CcSEcCtD
Vecuronium—Cardiac disorder—Capecitabine—prostate cancer	0.000234	0.00184	CcSEcCtD
Vecuronium—Flushing—Capecitabine—prostate cancer	0.000234	0.00184	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.00023	0.00182	CcSEcCtD
Vecuronium—Angiopathy—Capecitabine—prostate cancer	0.000228	0.0018	CcSEcCtD
Vecuronium—Rash—Goserelin—prostate cancer	0.000228	0.0018	CcSEcCtD
Vecuronium—Dermatitis—Goserelin—prostate cancer	0.000228	0.0018	CcSEcCtD
Vecuronium—Urticaria—Estradiol—prostate cancer	0.000228	0.0018	CcSEcCtD
Vecuronium—Immune system disorder—Capecitabine—prostate cancer	0.000227	0.00179	CcSEcCtD
Vecuronium—Mediastinal disorder—Capecitabine—prostate cancer	0.000227	0.00179	CcSEcCtD
Vecuronium—Face oedema—Doxorubicin—prostate cancer	0.000227	0.00179	CcSEcCtD
Vecuronium—Erythema—Docetaxel—prostate cancer	0.000226	0.00179	CcSEcCtD
Vecuronium—Rash—Conjugated Estrogens—prostate cancer	0.000226	0.00178	CcSEcCtD
Vecuronium—Dermatitis—Conjugated Estrogens—prostate cancer	0.000226	0.00178	CcSEcCtD
Vecuronium—CHRNB1—testis—prostate cancer	0.000225	0.0784	CbGeAlD
Vecuronium—Muscular weakness—Epirubicin—prostate cancer	0.000224	0.00176	CcSEcCtD
Vecuronium—Anaphylactic shock—Etoposide—prostate cancer	0.000222	0.00175	CcSEcCtD
Vecuronium—Connective tissue disorder—Prednisone—prostate cancer	0.00022	0.00174	CcSEcCtD
Vecuronium—Erythema—Capecitabine—prostate cancer	0.000219	0.00173	CcSEcCtD
Vecuronium—SLC22A1—renal system—prostate cancer	0.000219	0.0764	CbGeAlD
Vecuronium—Tachycardia—Etoposide—prostate cancer	0.000217	0.00171	CcSEcCtD
Vecuronium—Skin disorder—Etoposide—prostate cancer	0.000216	0.0017	CcSEcCtD
Vecuronium—Urticaria—Mitoxantrone—prostate cancer	0.000212	0.00167	CcSEcCtD
Vecuronium—Hypersensitivity—Estradiol—prostate cancer	0.000211	0.00167	CcSEcCtD
Vecuronium—Flushing—Prednisone—prostate cancer	0.000208	0.00164	CcSEcCtD
Vecuronium—Hypotension—Etoposide—prostate cancer	0.000208	0.00164	CcSEcCtD
Vecuronium—Muscular weakness—Doxorubicin—prostate cancer	0.000207	0.00163	CcSEcCtD
Vecuronium—Angiopathy—Prednisone—prostate cancer	0.000204	0.00161	CcSEcCtD
Vecuronium—Immune system disorder—Prednisone—prostate cancer	0.000203	0.0016	CcSEcCtD
Vecuronium—Hypersensitivity—Mitoxantrone—prostate cancer	0.000197	0.00155	CcSEcCtD
Vecuronium—Erythema—Prednisone—prostate cancer	0.000195	0.00154	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000191	0.00151	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000185	0.00146	CcSEcCtD
Vecuronium—Anaphylactic shock—Docetaxel—prostate cancer	0.000185	0.00146	CcSEcCtD
Vecuronium—Shock—Docetaxel—prostate cancer	0.000182	0.00143	CcSEcCtD
Vecuronium—Nervous system disorder—Docetaxel—prostate cancer	0.000181	0.00143	CcSEcCtD
Vecuronium—Rash—Estradiol—prostate cancer	0.000181	0.00143	CcSEcCtD
Vecuronium—Dermatitis—Estradiol—prostate cancer	0.000181	0.00143	CcSEcCtD
Vecuronium—Tachycardia—Docetaxel—prostate cancer	0.00018	0.00142	CcSEcCtD
Vecuronium—Skin disorder—Docetaxel—prostate cancer	0.000179	0.00142	CcSEcCtD
Vecuronium—Angioedema—Prednisone—prostate cancer	0.000178	0.00141	CcSEcCtD
Vecuronium—Urticaria—Etoposide—prostate cancer	0.000177	0.00139	CcSEcCtD
Vecuronium—Shock—Capecitabine—prostate cancer	0.000176	0.00139	CcSEcCtD
Vecuronium—Nervous system disorder—Capecitabine—prostate cancer	0.000175	0.00138	CcSEcCtD
Vecuronium—Tachycardia—Capecitabine—prostate cancer	0.000175	0.00138	CcSEcCtD
Vecuronium—Skin disorder—Capecitabine—prostate cancer	0.000174	0.00137	CcSEcCtD
Vecuronium—Hypotension—Docetaxel—prostate cancer	0.000173	0.00136	CcSEcCtD
Vecuronium—Connective tissue disorder—Epirubicin—prostate cancer	0.000172	0.00136	CcSEcCtD
Vecuronium—Rash—Mitoxantrone—prostate cancer	0.000169	0.00133	CcSEcCtD
Vecuronium—Dermatitis—Mitoxantrone—prostate cancer	0.000168	0.00133	CcSEcCtD
Vecuronium—Hypotension—Capecitabine—prostate cancer	0.000167	0.00132	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000165	0.0013	CcSEcCtD
Vecuronium—Hypersensitivity—Etoposide—prostate cancer	0.000164	0.00129	CcSEcCtD
Vecuronium—CHRNB1—lymph node—prostate cancer	0.000163	0.0569	CbGeAlD
Vecuronium—Flushing—Epirubicin—prostate cancer	0.000163	0.00128	CcSEcCtD
Vecuronium—Cardiac disorder—Epirubicin—prostate cancer	0.000163	0.00128	CcSEcCtD
Vecuronium—Connective tissue disorder—Doxorubicin—prostate cancer	0.00016	0.00126	CcSEcCtD
Vecuronium—Anaphylactic shock—Prednisone—prostate cancer	0.000159	0.00126	CcSEcCtD
Vecuronium—Angiopathy—Epirubicin—prostate cancer	0.000159	0.00126	CcSEcCtD
Vecuronium—Immune system disorder—Epirubicin—prostate cancer	0.000158	0.00125	CcSEcCtD
Vecuronium—Mediastinal disorder—Epirubicin—prostate cancer	0.000158	0.00125	CcSEcCtD
Vecuronium—Shock—Prednisone—prostate cancer	0.000157	0.00124	CcSEcCtD
Vecuronium—Nervous system disorder—Prednisone—prostate cancer	0.000156	0.00123	CcSEcCtD
Vecuronium—Tachycardia—Prednisone—prostate cancer	0.000156	0.00123	CcSEcCtD
Vecuronium—Skin disorder—Prednisone—prostate cancer	0.000155	0.00122	CcSEcCtD
Vecuronium—Erythema—Epirubicin—prostate cancer	0.000153	0.0012	CcSEcCtD
Vecuronium—Flushing—Doxorubicin—prostate cancer	0.000151	0.00119	CcSEcCtD
Vecuronium—Cardiac disorder—Doxorubicin—prostate cancer	0.000151	0.00119	CcSEcCtD
Vecuronium—Angiopathy—Doxorubicin—prostate cancer	0.000147	0.00116	CcSEcCtD
Vecuronium—Immune system disorder—Doxorubicin—prostate cancer	0.000147	0.00116	CcSEcCtD
Vecuronium—Mediastinal disorder—Doxorubicin—prostate cancer	0.000146	0.00115	CcSEcCtD
Vecuronium—Urticaria—Capecitabine—prostate cancer	0.000142	0.00112	CcSEcCtD
Vecuronium—Erythema—Doxorubicin—prostate cancer	0.000141	0.00111	CcSEcCtD
Vecuronium—Rash—Etoposide—prostate cancer	0.00014	0.00111	CcSEcCtD
Vecuronium—Dermatitis—Etoposide—prostate cancer	0.00014	0.0011	CcSEcCtD
Vecuronium—Hypersensitivity—Docetaxel—prostate cancer	0.000136	0.00107	CcSEcCtD
Vecuronium—Hypersensitivity—Capecitabine—prostate cancer	0.000132	0.00104	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000129	0.00102	CcSEcCtD
Vecuronium—Urticaria—Prednisone—prostate cancer	0.000127	0.000999	CcSEcCtD
Vecuronium—Anaphylactic shock—Epirubicin—prostate cancer	0.000125	0.000983	CcSEcCtD
Vecuronium—Shock—Epirubicin—prostate cancer	0.000123	0.000967	CcSEcCtD
Vecuronium—Nervous system disorder—Epirubicin—prostate cancer	0.000122	0.000964	CcSEcCtD
Vecuronium—Tachycardia—Epirubicin—prostate cancer	0.000122	0.000959	CcSEcCtD
Vecuronium—Skin disorder—Epirubicin—prostate cancer	0.000121	0.000955	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000119	0.000942	CcSEcCtD
Vecuronium—Hypersensitivity—Prednisone—prostate cancer	0.000117	0.000926	CcSEcCtD
Vecuronium—Rash—Docetaxel—prostate cancer	0.000117	0.000919	CcSEcCtD
Vecuronium—Hypotension—Epirubicin—prostate cancer	0.000116	0.000919	CcSEcCtD
Vecuronium—Dermatitis—Docetaxel—prostate cancer	0.000116	0.000918	CcSEcCtD
Vecuronium—Anaphylactic shock—Doxorubicin—prostate cancer	0.000115	0.00091	CcSEcCtD
Vecuronium—Shock—Doxorubicin—prostate cancer	0.000113	0.000895	CcSEcCtD
Vecuronium—Nervous system disorder—Doxorubicin—prostate cancer	0.000113	0.000892	CcSEcCtD
Vecuronium—Rash—Capecitabine—prostate cancer	0.000113	0.00089	CcSEcCtD
Vecuronium—Dermatitis—Capecitabine—prostate cancer	0.000113	0.000889	CcSEcCtD
Vecuronium—Tachycardia—Doxorubicin—prostate cancer	0.000113	0.000888	CcSEcCtD
Vecuronium—Skin disorder—Doxorubicin—prostate cancer	0.000112	0.000884	CcSEcCtD
Vecuronium—Hypotension—Doxorubicin—prostate cancer	0.000108	0.00085	CcSEcCtD
Vecuronium—ABCB1—prostate gland—prostate cancer	0.000104	0.0362	CbGeAlD
Vecuronium—Rash—Prednisone—prostate cancer	0.0001	0.000793	CcSEcCtD
Vecuronium—Dermatitis—Prednisone—prostate cancer	0.0001	0.000792	CcSEcCtD
Vecuronium—Urticaria—Epirubicin—prostate cancer	9.9e-05	0.000781	CcSEcCtD
Vecuronium—Hypersensitivity—Epirubicin—prostate cancer	9.18e-05	0.000724	CcSEcCtD
Vecuronium—Urticaria—Doxorubicin—prostate cancer	9.16e-05	0.000723	CcSEcCtD
Vecuronium—ABCB1—seminal vesicle—prostate cancer	8.76e-05	0.0306	CbGeAlD
Vecuronium—Hypersensitivity—Doxorubicin—prostate cancer	8.5e-05	0.00067	CcSEcCtD
Vecuronium—Rash—Epirubicin—prostate cancer	7.86e-05	0.00062	CcSEcCtD
Vecuronium—Dermatitis—Epirubicin—prostate cancer	7.85e-05	0.000619	CcSEcCtD
Vecuronium—ABCB1—epithelium—prostate cancer	7.61e-05	0.0266	CbGeAlD
Vecuronium—Rash—Doxorubicin—prostate cancer	7.27e-05	0.000574	CcSEcCtD
Vecuronium—Dermatitis—Doxorubicin—prostate cancer	7.26e-05	0.000573	CcSEcCtD
Vecuronium—ABCB1—renal system—prostate cancer	7.06e-05	0.0246	CbGeAlD
Vecuronium—ABCB1—urethra—prostate cancer	6.94e-05	0.0242	CbGeAlD
Vecuronium—ABCB1—bone marrow—prostate cancer	5.34e-05	0.0186	CbGeAlD
Vecuronium—ABCB1—testis—prostate cancer	4.56e-05	0.0159	CbGeAlD
Vecuronium—ABCB1—lymph node—prostate cancer	3.31e-05	0.0115	CbGeAlD
Vecuronium—SLC22A1—Metabolism—SRD5A2—prostate cancer	2.57e-05	0.000837	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—AR—prostate cancer	2.5e-05	0.000817	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	2.5e-05	0.000815	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	2.48e-05	0.00081	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSD17B1—prostate cancer	2.45e-05	0.000799	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	2.43e-05	0.000794	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	2.43e-05	0.000794	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CXCL8—prostate cancer	2.42e-05	0.000791	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—EP300—prostate cancer	2.4e-05	0.000783	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	2.33e-05	0.000759	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—CASP3—prostate cancer	2.32e-05	0.000757	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—IL2—prostate cancer	2.32e-05	0.000756	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	2.28e-05	0.000745	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—VEGFA—prostate cancer	2.27e-05	0.000742	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HAO1—prostate cancer	2.23e-05	0.000726	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	2.23e-05	0.000726	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	2.21e-05	0.000722	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HPGD—prostate cancer	2.18e-05	0.000712	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—B4GALT4—prostate cancer	2.18e-05	0.000712	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	2.13e-05	0.000696	CbGpPWpGaD
Vecuronium—SLC22A1—Transmission across Chemical Synapses—MDM2—prostate cancer	2.1e-05	0.000687	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.1e-05	0.000685	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TNFRSF21—prostate cancer	2.05e-05	0.000669	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	2.03e-05	0.000664	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2e-05	0.000653	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP7B1—prostate cancer	2e-05	0.000651	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTAP—prostate cancer	2e-05	0.000651	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	1.97e-05	0.000644	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—VEGFA—prostate cancer	1.97e-05	0.000643	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SULT1E1—prostate cancer	1.94e-05	0.000634	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SRD5A1—prostate cancer	1.94e-05	0.000634	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSD17B3—prostate cancer	1.85e-05	0.000605	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ACSL4—prostate cancer	1.85e-05	0.000605	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—ABCG5—prostate cancer	1.82e-05	0.000594	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PSAT1—prostate cancer	1.81e-05	0.000592	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GRHL1—prostate cancer	1.81e-05	0.000592	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ADI1—prostate cancer	1.81e-05	0.000592	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CSAD—prostate cancer	1.81e-05	0.000592	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CBR1—prostate cancer	1.81e-05	0.000592	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TST—prostate cancer	1.81e-05	0.000592	CbGpPWpGaD
Vecuronium—ABCB1—Allograft Rejection—TGFB1—prostate cancer	1.81e-05	0.00059	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ARG2—prostate cancer	1.78e-05	0.00058	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—UMPS—prostate cancer	1.78e-05	0.00058	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PHGDH—prostate cancer	1.78e-05	0.00058	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.77e-05	0.000577	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—LDHB—prostate cancer	1.74e-05	0.000569	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	1.73e-05	0.000566	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	1.72e-05	0.000561	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP3A5—prostate cancer	1.71e-05	0.000559	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GRHPR—prostate cancer	1.69e-05	0.000551	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CKMT2—prostate cancer	1.69e-05	0.000551	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UGT2B15—prostate cancer	1.69e-05	0.000551	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UGT2B17—prostate cancer	1.69e-05	0.000551	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.68e-05	0.000549	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	1.68e-05	0.000547	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—UCP3—prostate cancer	1.65e-05	0.000539	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PDHA1—prostate cancer	1.65e-05	0.000539	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA3—prostate cancer	1.65e-05	0.000539	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TCN2—prostate cancer	1.65e-05	0.000539	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	1.62e-05	0.00053	CbGpPWpGaD
Vecuronium—SLC22A1—Neuronal System—MDM2—prostate cancer	1.61e-05	0.000526	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.61e-05	0.000525	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	1.61e-05	0.000524	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AOX1—prostate cancer	1.59e-05	0.000518	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—RFK—prostate cancer	1.59e-05	0.000518	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PGAM2—prostate cancer	1.59e-05	0.000518	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MBTPS1—prostate cancer	1.59e-05	0.000518	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NAGLU—prostate cancer	1.59e-05	0.000518	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SULT2B1—prostate cancer	1.59e-05	0.000518	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTM3—prostate cancer	1.59e-05	0.000518	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC22A3—prostate cancer	1.58e-05	0.000515	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSD3B1—prostate cancer	1.58e-05	0.000515	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	1.53e-05	0.000499	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA4—prostate cancer	1.51e-05	0.000493	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TBXAS1—prostate cancer	1.51e-05	0.000493	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	1.51e-05	0.000492	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AMACR—prostate cancer	1.5e-05	0.000491	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP3A43—prostate cancer	1.5e-05	0.000491	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SRD5A2—prostate cancer	1.5e-05	0.000491	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NAT1—prostate cancer	1.5e-05	0.000491	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—DEGS1—prostate cancer	1.5e-05	0.000491	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	1.49e-05	0.000485	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA2—prostate cancer	1.47e-05	0.000481	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ABCG5—prostate cancer	1.46e-05	0.000475	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SULT1A1—prostate cancer	1.46e-05	0.000475	CbGpPWpGaD
Vecuronium—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	1.45e-05	0.000473	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	1.44e-05	0.000469	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSD17B1—prostate cancer	1.43e-05	0.000468	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTA1—prostate cancer	1.42e-05	0.000464	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NAT2—prostate cancer	1.41e-05	0.000459	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HSD3B2—prostate cancer	1.41e-05	0.000459	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTO1—prostate cancer	1.41e-05	0.000459	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	1.37e-05	0.000446	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PLCB2—prostate cancer	1.35e-05	0.00044	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—LRP2—prostate cancer	1.35e-05	0.00044	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2C18—prostate cancer	1.35e-05	0.00044	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—P4HB—prostate cancer	1.32e-05	0.000431	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.3e-05	0.000426	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	1.3e-05	0.000424	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.29e-05	0.000419	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	1.28e-05	0.000418	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—B4GALT4—prostate cancer	1.28e-05	0.000417	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HPGD—prostate cancer	1.28e-05	0.000417	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.26e-05	0.000412	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SULT2A1—prostate cancer	1.25e-05	0.000409	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.23e-05	0.000403	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MED12—prostate cancer	1.23e-05	0.000402	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.23e-05	0.000401	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GNG5—prostate cancer	1.22e-05	0.000399	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.2e-05	0.000392	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOA3—prostate cancer	1.18e-05	0.000384	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.17e-05	0.000383	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTAP—prostate cancer	1.17e-05	0.000382	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP7B1—prostate cancer	1.17e-05	0.000382	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.17e-05	0.000381	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.15e-05	0.000374	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SRD5A1—prostate cancer	1.14e-05	0.000372	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SULT1E1—prostate cancer	1.14e-05	0.000372	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—HPGDS—prostate cancer	1.12e-05	0.000367	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2C19—prostate cancer	1.12e-05	0.000364	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.11e-05	0.000364	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.1e-05	0.00036	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTT1—prostate cancer	1.09e-05	0.000356	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ACHE—prostate cancer	1.09e-05	0.000356	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSD17B3—prostate cancer	1.09e-05	0.000355	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ACSL4—prostate cancer	1.09e-05	0.000355	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.08e-05	0.000352	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2A6—prostate cancer	1.08e-05	0.000352	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.08e-05	0.000351	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AKR1C3—prostate cancer	1.05e-05	0.000342	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PRKACB—prostate cancer	1.04e-05	0.00034	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UMPS—prostate cancer	1.04e-05	0.00034	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PHGDH—prostate cancer	1.04e-05	0.00034	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ARG2—prostate cancer	1.04e-05	0.00034	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.04e-05	0.000338	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP17A1—prostate cancer	1.03e-05	0.000337	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.03e-05	0.000335	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—LDHB—prostate cancer	1.02e-05	0.000334	CbGpPWpGaD
Vecuronium—SLC22A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.02e-05	0.000333	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP3A5—prostate cancer	1e-05	0.000327	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	9.98e-06	0.000326	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	9.86e-06	0.000322	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOA2—prostate cancer	9.83e-06	0.000321	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	9.72e-06	0.000317	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PDHA1—prostate cancer	9.69e-06	0.000316	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—UCP3—prostate cancer	9.69e-06	0.000316	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TCN2—prostate cancer	9.69e-06	0.000316	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA3—prostate cancer	9.69e-06	0.000316	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—SLC5A5—prostate cancer	9.38e-06	0.000306	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSD3B1—prostate cancer	9.24e-06	0.000302	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC22A3—prostate cancer	9.24e-06	0.000302	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP2E1—prostate cancer	9.16e-06	0.000299	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NQO1—prostate cancer	9.06e-06	0.000296	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	8.94e-06	0.000292	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TH—prostate cancer	8.93e-06	0.000291	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	8.92e-06	0.000291	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA4—prostate cancer	8.86e-06	0.000289	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TBXAS1—prostate cancer	8.86e-06	0.000289	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP3A4—prostate cancer	8.83e-06	0.000288	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	8.74e-06	0.000285	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP1B1—prostate cancer	8.68e-06	0.000283	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA2—prostate cancer	8.64e-06	0.000282	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ABCG5—prostate cancer	8.53e-06	0.000278	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SULT1A1—prostate cancer	8.53e-06	0.000278	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GGT1—prostate cancer	8.41e-06	0.000274	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTA1—prostate cancer	8.33e-06	0.000272	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NCOA1—prostate cancer	8.28e-06	0.00027	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	8.26e-06	0.00027	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NAT2—prostate cancer	8.24e-06	0.000269	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTO1—prostate cancer	8.24e-06	0.000269	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HSD3B2—prostate cancer	8.24e-06	0.000269	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP19A1—prostate cancer	8.16e-06	0.000266	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—LRP2—prostate cancer	7.9e-06	0.000258	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PLCB2—prostate cancer	7.9e-06	0.000258	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2C18—prostate cancer	7.9e-06	0.000258	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—RXRA—prostate cancer	7.88e-06	0.000257	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—P4HB—prostate cancer	7.75e-06	0.000253	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—COMT—prostate cancer	7.59e-06	0.000248	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	7.59e-06	0.000248	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTP1—prostate cancer	7.55e-06	0.000247	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC22A1—prostate cancer	7.54e-06	0.000246	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	7.53e-06	0.000246	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ITPR1—prostate cancer	7.43e-06	0.000243	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SULT2A1—prostate cancer	7.34e-06	0.00024	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	7.34e-06	0.00024	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MED12—prostate cancer	7.22e-06	0.000236	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GNG5—prostate cancer	7.17e-06	0.000234	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—TYMS—prostate cancer	7.02e-06	0.000229	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—GSTM1—prostate cancer	6.94e-06	0.000227	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOA3—prostate cancer	6.9e-06	0.000225	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—LPL—prostate cancer	6.81e-06	0.000222	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—HPGDS—prostate cancer	6.59e-06	0.000215	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CYP1A1—prostate cancer	6.58e-06	0.000215	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2C19—prostate cancer	6.54e-06	0.000214	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—ERCC2—prostate cancer	6.53e-06	0.000213	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ACHE—prostate cancer	6.39e-06	0.000208	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTT1—prostate cancer	6.39e-06	0.000208	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2A6—prostate cancer	6.31e-06	0.000206	CbGpPWpGaD
Vecuronium—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.2e-06	0.000202	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AKR1C3—prostate cancer	6.14e-06	0.0002	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—MTHFR—prostate cancer	6.14e-06	0.0002	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PRKACB—prostate cancer	6.11e-06	0.000199	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP17A1—prostate cancer	6.05e-06	0.000197	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PPARA—prostate cancer	6.02e-06	0.000196	CbGpPWpGaD
Vecuronium—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.98e-06	0.000195	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOA2—prostate cancer	5.76e-06	0.000188	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CAV1—prostate cancer	5.66e-06	0.000185	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—SLC5A5—prostate cancer	5.5e-06	0.000179	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP2E1—prostate cancer	5.37e-06	0.000175	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NQO1—prostate cancer	5.31e-06	0.000173	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TH—prostate cancer	5.23e-06	0.000171	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP3A4—prostate cancer	5.18e-06	0.000169	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CG—prostate cancer	5.15e-06	0.000168	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP1B1—prostate cancer	5.09e-06	0.000166	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GGT1—prostate cancer	4.93e-06	0.000161	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—INS—prostate cancer	4.88e-06	0.000159	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NCOA1—prostate cancer	4.86e-06	0.000158	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP19A1—prostate cancer	4.79e-06	0.000156	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—CREBBP—prostate cancer	4.78e-06	0.000156	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—RXRA—prostate cancer	4.62e-06	0.000151	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CD—prostate cancer	4.53e-06	0.000148	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—COMT—prostate cancer	4.45e-06	0.000145	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTP1—prostate cancer	4.43e-06	0.000145	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ITPR1—prostate cancer	4.36e-06	0.000142	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—NOS3—prostate cancer	4.28e-06	0.00014	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—TYMS—prostate cancer	4.12e-06	0.000134	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—GSTM1—prostate cancer	4.07e-06	0.000133	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—LPL—prostate cancer	3.99e-06	0.00013	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CB—prostate cancer	3.95e-06	0.000129	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTGS2—prostate cancer	3.91e-06	0.000128	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CYP1A1—prostate cancer	3.86e-06	0.000126	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—ERCC2—prostate cancer	3.83e-06	0.000125	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—MTHFR—prostate cancer	3.6e-06	0.000117	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PPARA—prostate cancer	3.53e-06	0.000115	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PTEN—prostate cancer	3.41e-06	0.000111	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CAV1—prostate cancer	3.32e-06	0.000108	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—EP300—prostate cancer	3.26e-06	0.000106	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CG—prostate cancer	3.02e-06	9.86e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—INS—prostate cancer	2.86e-06	9.33e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—CREBBP—prostate cancer	2.8e-06	9.14e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CD—prostate cancer	2.66e-06	8.67e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—NOS3—prostate cancer	2.51e-06	8.19e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—PIK3CA—prostate cancer	2.41e-06	7.86e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CB—prostate cancer	2.32e-06	7.56e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTGS2—prostate cancer	2.29e-06	7.49e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PTEN—prostate cancer	2e-06	6.53e-05	CbGpPWpGaD
Vecuronium—SLC22A1—Metabolism—AKT1—prostate cancer	1.97e-06	6.42e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—EP300—prostate cancer	1.91e-06	6.23e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—PIK3CA—prostate cancer	1.41e-06	4.61e-05	CbGpPWpGaD
Vecuronium—ABCB1—Metabolism—AKT1—prostate cancer	1.15e-06	3.76e-05	CbGpPWpGaD
